Observe Medical ASA: Status update on Letters of Intent
Oslo, 3 March 2023 – Observe Medical ASA (“the Company” or “Observe Medical”) today provides an update on the initial letters of intent (LOIs) that have been sent to distributors of the Unometer portfolio. As previously announced, Observe Medical is in the process of confirming orders with distributors of Unometer Safeti Plus, AbdoPressure and Sippi. Since the first LOIs were sent out in the middle of February 2023, the order value of those that have been signed and returned for the Unometer urine measurement system amount to approximately EUR 1 million. The company expects further